Table 1 FA profile and daily FA dose with run-in oil and with treatment oilsa
Run-in period (2 weeks) | Intervention period (8 weeks) | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
Treatment | Run-in oil (n = 155) | Echium oil (study 1) (n = 59) | Linseed oil mixture (study 2) (n = 59) | Control groups | ||||||
Fish oilb (study 1) (n = 19) | Olive oil (study 2) (n = 18) | |||||||||
% | g/d | % | g/d | % | g/d | % | g/d | % | g/d | |
Oil dose | 17 | 17 | 17 | 17 | 17 | |||||
FA groups and individual FA | ||||||||||
∑SFA | 44 | 7.5 | 11 | 1.8 | 9.0 | 1.4 | 12 | 2.1 | 14 | 2.1 |
∑MUFA (mainly 18:1n-9) | 39 | 6.7 | 18 | 3.0 | 38 | 5.9 | 66 | 12 | 80 | 12 |
∑PUFA | 16 | 2.8 | 70 | 12 | 53 | 8.1 | 22 | 3.3 | 6.0 | 0.9 |
18:2n-6, LA | 16 | 2.8 | 17 | 2.9 | 22 | 3.3 | 5.7 | 0.9 | 5.5 | 0.8 |
18:3n-6, GLA | − | − | 11 | 1.8 | − | − | 0.1 | − | − | − |
18:3n-3, ALA | 0.2 | − | 30 | 5.0 | 31 | 4.9 | 0.6 | 0.1 | 0.5 | 0.1 |
18:4n-3, SDA | − | − | 12 | 2.0 | − | − | 1.2 | 0.2 | − | − |
20:5n-3, EPA | − | − | − | − | − | − | 11 | 1.9 | − | − |
22:5n-3, DPA | − | − | − | − | − | − | 0.2 | − | − | − |
22:6n-3, DHA | − | − | − | − | − | − | 1.4 | 0.2 | − | − |
n-6/n-3 | 80/1 | 0.7/1 | 0.7/1 | 0.4/1 | 11/1 | |||||